Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
104.00    0.80 (0.78%)
Bid:
104.00
Ask:
105.00
Spread: 1.00 (0.962%)
Market Cap: £170.50m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Interim Management Statement

6 May 2010 11:00

RNS Number : 4369L
Yule Catto & Co PLC
06 May 2010
 



6 May 2010

 

Yule Catto & Co plc 

 

Interim Management Statement

 

Yule Catto & Co plc, the international producer of speciality chemicals, today issues its Interim Management Statement for the period from 1 January to 31 March 2010

 

 

The Group has made a good start to the year with first quarter PBT comfortably ahead of last year.

 

Polymer Chemicals is the Group's main business, accounting for 88% of divisional operating profit in 2009 with 50% of its revenue in Asia and emerging markets. The business made a good start to the year. Volumes were over 10% up on prior year, strongly ahead of the weak first quarter of 2009. Volumes in Asia remain strong. Whilst Europe started slowly, in part due to the difficult weather conditions, demand strengthened through the quarter and this has continued into April. Monomer prices continued to rise through the quarter and the business has continued to seek to recover these increases in the market place.

 

Pharma Chemicals has continued to trade weakly, with profits in the first quarter below prior year, though the business has a good current forward order book.

 

William Blythe, the remaining Impact Chemicals business was ahead of last year as expected.

 

Net debt rose during the quarter, as the improving demand position absorbed additional working capital, but is still comfortably below £100 million. We are still in the process of completing the announced sale of the Finewaters adhesive business, which will deliver a further reduction in debt of £11 million when concluded.

 

Looking forward in Polymers we expect to see continuing strong demand in Asia and modest volume improvement in Europe. Monomer prices have continued to rise during the second quarter and work is in hand to recover these increases. Pharma, after the slow start, is likely to trade a little below last year, whilst William Blythe will be ahead. Overall trading is in line with the Board's previous expectations for the full year.

 

 

ENQUIRIES:

 

YULE CATTO & Co plc

Tel: 01279 442791

Adrian Whitfield, Chief Executive

David Blackwood, Finance Director

HOGARTH

Tel: 020 7357 9477

John Olsen

Andrew Jaques

Ian Payne

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSLIFLTEFIRIII
Date   Source Headline
26th Sep 20169:25 amRNSHolding(s) in Company
14th Sep 20163:10 pmRNSHolding(s) in Company
14th Sep 20163:01 pmRNSHolding(s) in Company
11th Aug 20161:15 pmRNSDisposal
9th Aug 20167:00 amRNSInterim Results for six months ended 30 June 2016
7th Jul 201611:50 amRNSHolding(s) in Company
7th Jul 201610:28 amRNSDirector/PDMR Shareholding
5th Jul 201611:57 amRNSHolding(s) in Company
1st Jul 20167:00 amRNSCompletion of acquisition and trading update
31st May 201611:31 amRNSAudit Tender
16th May 20164:17 pmRNSHolding(s) in Company
9th May 201612:31 pmRNSDirector/PDMR Shareholding
28th Apr 20163:11 pmRNSResult of AGM
28th Apr 20167:00 amRNSQ1 Trading update
21st Apr 20161:44 pmRNSHolding(s) in Company
20th Apr 20162:23 pmRNSDirector Declaration
11th Apr 20163:01 pmRNSDirector/PDMR Shareholding
11th Apr 20163:00 pmRNSDirector/PDMR Shareholding
31st Mar 20162:15 pmRNSAnnual Financial Report
21st Mar 20167:00 amRNSAcquisition
21st Mar 20167:00 amRNSDisposal
15th Mar 201612:29 pmRNSHolding(s) in Company
2nd Mar 20167:00 amRNSPreliminary Results for the year ended 31 Dec 2015
10th Feb 20167:00 amRNSFRS 101 Notification
5th Feb 20163:34 pmRNSHolding(s) in Company
5th Feb 20163:13 pmRNSHolding(s) in Company
30th Nov 20153:00 pmRNSHolding(s) in Company
18th Nov 201510:30 amRNSDirector/PDMR Shareholding
6th Nov 20157:00 amRNSQ3 Trading Update
1st Oct 201512:50 pmRNSHolding(s) in Company
13th Aug 201510:05 amRNSHolding(s) in Company
11th Aug 20157:00 amRNSHalf Yearly Results
10th Jul 20152:43 pmRNSDirector/PDMR Shareholding
9th Jul 20159:12 amRNSHolding(s) in Company
7th Jul 20154:21 pmRNSHolding(s) in Company
6th Jul 20153:59 pmRNSHolding(s) in Company
2nd Jul 20157:00 amRNSTrading Update
22nd Jun 20153:51 pmRNSHolding(s) in Company
20th May 20158:57 amRNSHolding(s) in Company
14th May 201510:02 amRNSDirector/PDMR Shareholding
30th Apr 201512:53 pmRNSResult of AGM
30th Apr 201512:46 pmRNSDirectorate Change
30th Apr 20157:00 amRNSQuarter 1 Trading Update
27th Apr 201510:36 amRNSDirectorate Change
21st Apr 20155:16 pmRNSHolding(s) in Company
1st Apr 20158:15 amRNSDirectorate Change
31st Mar 20159:25 amRNSAnnual Financial Report
30th Mar 201510:13 amRNSHolding(s) in Company
27th Mar 201512:53 pmRNSDirector/PDMR Shareholding
23rd Mar 20157:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.